Skip to main content

JANE STREET GROUP, LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in LCTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,569,267
-$108,737 QoQ
Shares Held
993,208
-1.2% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Derivatives in LCTX

reported options exposure · as of Sep 30, 2025
CallValue
$40,729
CallShares
24,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. LCTX ranks #97 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LCTX

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,569,267 993,208
2025-12-31 $1,678,004 1,004,794
2025-09-30 $244,817 144,863
2025-09-30 $40,729 24,100
2025-06-30 $1,370,820 1,506,396
2025-06-30 $58,149 63,900
2025-03-31 $30,630 68,068
2024-12-31 $131,433 262,866
2024-09-30 $109,109 119,901
2024-06-30 $242,955 242,955
2024-03-31 $155,103 104,800
2023-12-31 $178,771 164,011
2023-09-30 $49,622 42,053
2023-06-30 $33,022 23,420
2023-03-31 $894,666 596,444
2022-12-31 $165,256 141,245
2022-09-30 $38,444 34,022
2022-06-30 $93,183 58,977
2022-03-31 $191,283 124,210
2021-12-31 $651,886 266,076
2021-12-31 $110,005 44,900
2021-09-30 $157,623 62,549
2021-06-30 $649,987 228,066
2021-03-31 $165,771 70,541
2020-12-31 $54,058 30,715
2020-09-30 $172,715 183,740
2020-06-30 $866,741 996,255
2020-03-31 $157,658 189,951